查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611110

神經調節設備的全球市場規模、佔有率和趨勢分析：按產品、應用、最終用途和地區（2025-2030）

Neuromodulation Devices Market Size, Share & Trends Analysis By Product (Spinal Cord Stimulators, Deep Brain Stimulators), By Application (Parkinson's Disease, Chronic Pain), By End-use, By Region, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

神經調節設備市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球神經調節設備市場規模將達到103.9億美元，2025年至2030年複合年成長率為8.51%。

市場成長的原因包括神經系統疾病盛行率上升、政府對研發的支持力度加大以及先進解決方案的開發和應用範圍的擴大等。

政府和私人機構的大量資助在增進對神經系統疾病的了解和改善治療方法發揮著重要作用。透過向研究舉措分配資源，政府積極培養突破性發現，鼓勵創新，並促進更有效的神經調節技術的發展。例如，帕金森基金會於 2024 年 8 月宣布，將向 33 項研究津貼約 300 萬美元，旨在促進對帕金森氏症 (PD) 的了解和治療。這筆津貼將支持專注於帕金森氏症各個方面的創新研究計劃，包括其病因、進展和潛在的治療方法。這筆津貼是基金會致力於促進科學進步、改善病患治療效果的承諾的一部分。這種財政支持對於塑造神經系統疾病的治療格局和為患者護理帶來積極的變化至關重要。

此外，這些先進設備對患者和醫療保健專業人員的可用性不斷提高，進一步提高了它們的採用率。醫療費用的增加也增加了患者獲得這些先進治療的機會。近年來，醫療保健系統越來越認知到神經調節設備在治療慢性疼痛、神經系統疾病和各種其他醫療狀況方面的有效性，許多醫療保健支付者將這些設備納入其承保政策中。例如，2024年2月，在美國，Highmark Inc.因其Nerivio遠端電神經調節（REN）穿戴裝置成為首個獲得商業保險承保的非藥物偏頭痛治療藥物。這款穿戴式裝置提供急性和預防性治療選擇，並在緩解偏頭痛症狀方面顯示出顯著的臨床療效。付款人對神經調節療法的日益接受度正在推動市場成長。

神經調節設備市場報告亮點

  • 脊髓刺激裝置佔最大市場佔有率，2024年約為39.67%。脊髓刺激裝置主要用於非手術疼痛治療無法充分緩解疼痛的患者。
  • 帕金森氏症佔最大市場佔有率，2024年約為26.90%。帕金森氏症患者病率不斷上升，加上人們越來越接受深部腦部刺激作為有效的治療選擇，預計將推動該領域的成長。
  • 到 2024 年，醫院和門診手術中心 (ASC) 佔據最大的市場佔有率，預計該細分市場在預測期內將呈現最快的成長。
  • 由於阿茲海默症、帕金森氏症、癲癇等各種神經疾病的盛行率不斷增加，以及對微創神經手術的需求不斷增加，2024年北美神經調節設備市場將佔據43.68%的佔有率。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 神經調節裝置的變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 神經調節裝置分析工具
    • 產業分析：波特五力分析
    • PESTEL分析

第 4 章 神經調節設備市場 - 細分分析：依產品（2018-2030）

  • 神經調節設備市場：產品展望與要點
  • 神經調節設備市場：產品變異分析
  • 依產品
  • 脊髓刺激裝置
    • 脊髓刺激裝置市場（2018-2030）
  • 腦深部電刺激裝置
    • 腦深部刺激設備市場（2018-2030）
  • 薦椎神經刺激裝置
    • 薦椎神經刺激裝置市場（2018-2030）
  • 迷走神經刺激裝置
    • 迷走神經刺激裝置市場（2018-2030）
  • 胃電刺激
    • 胃電刺激市場（2018-2030）
  • 其他
    • 其他市場（2018-2030）

第 5 章 神經調節設備市場 - 細分分析：依應用分類（2018-2030）

  • 神經調節設備市場：應用前景與重點
  • 神經調節設備市場：應用變化分析
  • 按用途
  • 帕金森氏症
    • 帕金森氏症市場（2018-2030）
  • 慢性疼痛
    • 慢性疼痛市場（2018-2030）
  • 癲癇
    • 癲癇市場（2018-2030）
  • 偏頭痛
    • 偏頭痛市場（2018-2030）
  • 尿失禁和大便失禁
    • 尿失禁和大便失禁市場（2018-2030）
  • 震顫
    • 震顫市場（2018-2030）
  • 憂鬱症
    • 憂鬱症市場（2018-2030）
  • 其他
    • 其他市場（2018-2030）

第 6 章 神經調節設備市場 - 細分分析：依最終用途分類（2018-2030）

  • 神經調節設備市場：最終用途展望與要點
  • 神經調節設備市場：最終用途變化分析
  • 按最終用途
  • 醫院和門診手術中心 (ASC)
    • 醫院和門診手術中心 (ASC) 市場（2018-2030）
  • 診所和物理治療中心
    • 診所和物理治療中心市場（2018-2030）
  • 其他
    • 其他市場（2018-2030）

第7章神經調節設備市場：區域估計與趨勢分析

  • 區域儀表板
  • 市場規模及預測趨勢分析（2018-2030）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
  • 主要市場參與企業的最新趨勢和影響分析
  • 企業市場佔有率分析：2024 年
  • 主要企業簡介
    • Abbott
    • Medtronic
    • Boston Scientific Corporation
    • Nexstim
    • LivaNova PLC
    • Neuropace Inc.
    • Nevro Corporation
    • electroCore, Inc.
    • Axonics, Inc.
    • Laborie
Product Code: GVR-4-68039-958-9

Neuromodulation Devices Market Growth & Trends:

The global neuromodulation devices market size is expected to reach USD 10.39 billion by 2030, registering a CAGR of 8.51% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market's growth can be attributed to factors such as rising prevalence of neurological disorders, rising government support to R&D and development of advanced solutions with increased range of applications.

Significant funding from government and private agencies plays a crucial role in advancing the understanding of neurological disorders and improving treatment options. By allocating resources to research initiatives, governments actively facilitate groundbreaking discoveries, encourage technological innovations, and promote the development of more effective neuromodulation technologies. For instance, in August 2024, the Parkinson's Foundation announced an investment of nearly USD 3 million in 33 research grants aimed at advancing the understanding and treatment of Parkinson's disease (PD). This funding will support innovative research projects focusing on various aspects of PD, including its causes, progression, and potential therapies. The grants are part of the Foundation's commitment to fostering scientific advancements that can lead to improved patient outcomes. This financial backing is vital for shaping the treatment landscape for neurological disorders and driving positive changes in patient care.

Furthermore, the increasing accessibility of these advanced devices to patients and healthcare professionals has further increased their adoption. Expanding reimbursement is improving patient access to these advanced therapies. In recent years, healthcare systems have increasingly acknowledged the effectiveness of neuromodulation devices in managing chronic pain, neurological disorders, and various other medical conditions, which has led many healthcare payers to include these devices in their coverage policies. For instance, in February 2024, Nerivio Remote Electrical Neuromodulation (REN) wearable by Theranica became the first non-pharmacological migraine treatment to get commercial coverage in the U.S. from Highmark Inc. The wearable offers acute and preventive treatment options, demonstrating significant clinical benefits in reducing migraine symptoms. Thus, the growing acceptance of neuromodulation therapies among payers is driving market growth.

Neuromodulation Devices Market Report Highlights:

  • Spinal cord stimulators held the largest market share of around 39.67% in 2024. Spinal cord stimulation devices are primarily used for patients without sufficient pain relief from non-surgical pain treatments.
  • Parkinson's disease held the largest market share of around 26.90% in 2024. The rising prevalence of Parkinson's disease, coupled with the increasing acceptance of deep brain stimulation as an effective treatment option, is expected to drive segment growth.
  • Hospitals & Ambulatory Surgery Centers (ASC) held the largest market share in 2024 and the same segments are expected to show fastest growth during the forecast period.
  • North America neuromodulation devices market dominated with a share of 43.68% in 2024, owing to increase in the prevalence of various neurological disorders, such as Alzheimer's disease, Parkinson's disease, and epilepsy, and a rise in the demand for minimally invasive neurological procedures.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Neuromodulation Devices Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Government funding for research and development
      • 3.2.1.2. Technological advancements in neuromodulation devices
      • 3.2.1.3. Increasing prevalence of neurological disorders
      • 3.2.1.4. Growing reimbursement coverage
      • 3.2.1.5. Expanding applications
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Complex regulatory framework
      • 3.2.2.2. Surgery-associated risk
  • 3.3. Neuromodulation Devices Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Neuromodulation Devices Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 4.1. Neuromodulation Devices Market: Product Outlook and Key Takeaways
  • 4.2. Neuromodulation Devices Market: Product Movement Analysis
  • 4.3. Neuromodulation Devices Market Estimates & Forecast, by Product (USD Million)
  • 4.4. Spinal Cord Stimulators
    • 4.4.1. Spinal Cord Stimulators Market, 2018 - 2030 (USD Million)
  • 4.5. Deep Brain Stimulators
    • 4.5.1. Deep Brain Stimulators Market, 2018 - 2030 (USD Million)
  • 4.6. Sacral Nerve Stimulators
    • 4.6.1. Sacral Nerve Stimulators Market, 2018 - 2030 (USD Million)
  • 4.7. Vagus Nerve Stimulators
    • 4.7.1. Vagus Nerve Stimulators Market, 2018 - 2030 (USD Million)
  • 4.8. Gastric Electrical Stimulation
    • 4.8.1. Gastric Electrical Stimulation Market, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Neuromodulation Devices Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)

  • 5.1. Neuromodulation Devices Market: Application Outlook and Key Takeaways
  • 5.2. Neuromodulation Devices Market: Application Movement Analysis
  • 5.3. Neuromodulation Devices Market Estimates & Forecast, by Application (USD Million)
  • 5.4. Parkinson's Disease
    • 5.4.1. Parkinson's Disease Market, 2018 - 2030 (USD Million)
  • 5.5. Chronic Pain
    • 5.5.1. Chronic Pain Market, 2018 - 2030 (USD Million)
  • 5.6. Epilepsy
    • 5.6.1. Epilepsy Market, 2018 - 2030 (USD Million)
  • 5.7. Migraine
    • 5.7.1. Migraine Market, 2018 - 2030 (USD Million)
  • 5.8. Urinary & Faecal Incontinence
    • 5.8.1. Urinary & Faecal Incontinence Market, 2018 - 2030 (USD Million)
  • 5.9. Tremor
    • 5.9.1. Tremor Market, 2018 - 2030 (USD Million)
  • 5.10. Depression
    • 5.10.1. Depression Market, 2018 - 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Neuromodulation Devices Market - Segment Analysis, by End Use, 2018 - 2030 (USD Million)

  • 6.1. Neuromodulation Devices Market: End Use Outlook and Key Takeaways
  • 6.2. Neuromodulation Devices Market: End Use Movement Analysis
  • 6.3. Neuromodulation Devices Market Estimates & Forecast, by End Use (USD Million)
  • 6.4. Hospitals & Ambulatory Surgery Centers (ASC)
    • 6.4.1. Hospitals & Ambulatory Surgery Centers (ASC) Market, 2018 - 2030 (USD Million)
  • 6.5. Clinics & Physiotherapy Centers
    • 6.5.1. Clinics & Physiotherapy Centers Market, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2018 - 2030 (USD Million

Chapter 7. Neuromodulation Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Recent Developments & Impact Analysis by Key Market Participants
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. Key Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Medtronic
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Boston Scientific Corporation
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Nexstim
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. LivaNova PLC
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Neuropace Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Nevro Corporation
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. electroCore, Inc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Axonics, Inc.
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Laborie
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America neuromodulation devices market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 4 North America neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 7 U.S. neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 10 Canada neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Mexico neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 13 Mexico neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe neuromodulation devices market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 17 Europe neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Germany neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 20 Germany neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 UK neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 23 UK neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 France neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 26 France neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 27 France neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Italy neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 29 Italy neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Spain neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Spain neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Denmark neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 35 Denmark neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Sweden neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 38 Sweden neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Norway neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 41 Norway neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific neuromodulation devices market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 China neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 48 China neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 49 China neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Japan neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 51 Japan neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 52 Japan neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 India neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 54 India neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 55 India neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Korea neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 57 South Korea neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Australia neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 60 Australia neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Thailand neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 63 Thailand neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 66 Latin America neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 68 Brazil neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 69 Brazil neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 70 Brazil neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Argentina neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Argentina neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 73 Argentina neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 MEA neuromodulation devices market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 76 MEA neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 77 MEA neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 South Africa neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 79 South Africa neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 80 South Africa neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 84 UAE neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 85 UAE neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 86 UAE neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 Kuwait neuromodulation devices market, by Product, 2018 - 2030 (USD Million)
  • Table 88 Kuwait neuromodulation devices market, by application, 2018 - 2030 (USD Million)
  • Table 89 Kuwait neuromodulation devices market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Neuromodulation devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot (global and regional)
  • Fig. 8 Product & end use segment snapshot
  • Fig. 9 Application segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Neurovascular devices market and neuromodulation devices market value
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 PESTLE analysis
  • Fig. 14 Neuromodulation devices market: Product outlook and key takeaways
  • Fig. 15 Neuromodulation devices market: Product movement analysis
  • Fig. 16 Spinal cord stimulation market estimates and forecast
  • Fig. 17 Deep brain stimulation market estimates and forecast
  • Fig. 18 Vagus nerve stimulation market estimates and forecast
  • Fig. 19 Sacral nerve stimulation market estimates and forecast
  • Fig. 20 Gastric electrical stimulation market estimates and forecast
  • Fig. 21 Others market estimates and forecast
  • Fig. 22 Neuromodulation devices market: Application outlook and key takeaways
  • Fig. 23 Neuromodulation devices market: Application movement analysis
  • Fig. 24 Parkinson's disease market estimates and forecast
  • Fig. 25 Chronic pain market estimates and forecast
  • Fig. 26 Migraine market estimates and forecast
  • Fig. 27 Epilepsy market estimates and forecast
  • Fig. 28 Tremor market estimates and forecast
  • Fig. 29 Country-wise depression prevalence
  • Fig. 30 Depression market estimates and forecast
  • Fig. 31 Urinary & fecal incontinence market estimates and forecast
  • Fig. 32 Others incontinence market estimates and forecast
  • Fig. 33 Neuromodulation devices market: End-use outlook and key takeaways
  • Fig. 34 Neuromodulation devices market: End-use movement analysis
  • Fig. 35 Hospitals & ambulatory surgical centers market estimates and forecast
  • Fig. 36 Clinics & physiotherapy centers market estimates and forecast
  • Fig. 37 Others market estimates and forecast
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Regional marketplace: Key takeaways
  • Fig. 40 North America neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 U.S. neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Canada neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Mexico neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Europe neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 UK neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Germany neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 France neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Italy neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Spain neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Sweden neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Denmark neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Norway neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 64 Asia Pacific neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Japan neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 China neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 India neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Australia neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 New Zealand neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 South Korea neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Thailand neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 79 Latin America neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Brazil neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Argentina neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 84 Middle East & Africa neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 South Africa neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Saudi Arabia neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 UAE neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Kuwait neuromodulation devices market, 2018 - 2030 (USD Million)
  • Fig. 93 Key company categorization
  • Fig. 94 Strategic framework